Arctium lappa is a perennial species of the Asteraceae family originally from Europe and Asia. Considered a weed species in the southern region of Brazil, it is popularly used as a natural anti-inflammatory. The complement system is an important component of the innate immune response. However, its exacerbated activation can lead to harmful conditions like autoimmune and inflammatory disorders. Plants that inhibit the activation of complement can be a promising tool in the treatment of inflammatory diseases. Here, we evaluated the effect of A. lappa leaves extracts on the activation of the classical and alternative pathways of complement system. Two extracts were obtained under supercritical conditions using scCO 2 with ethanol as cosolvent, at 313.15K, 15 MPa (E1) and 25 MPa (E2). Classical and alternative activation were evaluated using complement fixation test. Different concentrations of A. lappa extracts E1 and E2 showed an inhibitory effect on both complement pathways, and heparin was used as control. The IC 50 of E1, E2, and heparin were 28.26, 20.12 and 92.54 µg/mL for classical and 26.12, 27.70, 27.78 µg/mL for the alternative pathway. Results demonstrate that A. lappa is a promising complementary treatment for diseases associated with complement activation.
Introduction
The plant Arctium lappa L., popularly known as Burdock, originally from Europe and Asia, is a perennial species of the Asteraceae family [1] . Burdock grows in all Brazilian territory with impressive spread. Considered a weed species in the southern region, it is popularly used for the treatment of skin injuries as well as depurative and anti-inflammatory [1, 2] . It is also consumed as infusion, decoction, or externally used as a plaster [3] . Moreover, Burdock has been used in traditional Chinese medicine and in alternative ther-apies in Europe, Asia, and North and South America [1, 2] . Several parts of this medicinal herb, including, roots, leaves, seeds, and fruits, have different scientifically proven biological activities such as hypolipidemic [4] , anti-inflammatory [5, 6] , antifungal [6] , and antitumor properties [7] . In addition, Holetz et al. demonstrated that the extracts of A. lappa from plants collected in southern Brazil presented bactericidal activity against Gram-positive and Gramnegative bacteria [2] . The major active compounds isolated from A. lappa include tannin, arctigenin, arctiin, beta-eudesmol, caffeic acid, chlorogenic acid, inulin, trachelogenin 4, sitosterol-beta-Dglucopyran-oside, lappaol, and diarctigenin [1] .
The complement system is one of the main effector branches of the innate immune response. It is constituted by more than 35 soluble or cell membrane proteins that can be activated by 3 pathways: classical, alternative, and lectin [8] . While the classical pathway is activated primarily by the recognition of immune complexes [9] , the alternative starts with the spontaneous hydrolysis of the component C3. In the lectin pathway, collectins or ficolins recognize microorganisms' carbohydrates, such as mannose and acetylated compounds, inducing its activation [9, 10] . Once complement becomes activated, all pathways culminate with the formation of C3 and C5 convertases, leading to the production of anaphylatoxins and the membrane attack complex (MAC) [8] . As a consequence of complement activation several biological processes take place, including opsonization, phagocytosis, inflammation, leukocyte chemotaxis, release of histamine from mast cells, active leukocyte oxygen species, vasoconstriction, increased vessel permeability, platelet aggregation, and cytolysis, among others [8, 11] .
It is well known that complement plays a pivotal role in host defense against pathogens. However, when its activation becomes exacerbated or uncontrolled it can lead to harmful reactions, such as those seen in autoimmune and inflammatory diseases [12] . Therefore, the modulation or inhibition of complement activation is an important target for therapies in the treatment of inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, atypical uremic hemolytic syndrome, Alzheimer's disease, atherosclerosis, paroxysmal nocturnal hemoglobinuria, and psoriasis, among others [13] . Despite the variety of natural products with diverse biological activities, including antiviral, analgesic, antitumor, antiallergic, anti-inflammatory, and immunomodulatory [14] , natural compounds with action on complement activation are scarce [13] . Since the activation or imbalance of the complement system may be associated with several inflammatory disorders, the investigation of vegetal species that can act as inhibitors of complement is of clinical relevance.
Previous studies have identified bioactive compounds of A. lappa extracted by conventional extraction techniques, such as low pressure methods (Soxhlet), ultrasound, and microwave [15] [16] [17] . However, these techniques require the use of high temperatures for long extraction times, which can lead to the loss of thermosensitive compounds. In addition, there is a search for techniques considered unconventional that use lower amounts of solvents, causing less environmental impact and still presenting good yields. Thus, supercritical extraction process is the most appropriate technology to obtain extracts with low residual solvent content and low final toxic potential [18] , being a great alternative as presented in previously studies [19, 20] . Considering that the extracts of A. lappa leaves obtained from the mixture of supercritical carbon dioxide (scCO 2 ) as solvent with ethanol as cosolvent showed higher efficiency, the best conditions of overall extraction yield were obtained at 313.15K and both pressures 15 and 25 MPa, and due to the great antioxidant effect that has already presented [19] , these same extracts were chosen to evaluate complement modulation. Therefore, as natural products may represent a complementary approach for the treatment of inflammatory diseases associated with exacerbated complement activity, our aim is to evaluate the effect of supercritical extracts from A. lappa leaves on the activation of the classical and alternative pathways of complement.
Results
The extracts E1 and E2 of A. lappa showed inhibitory effect on the activation of both classical and alternative pathways when compared to the positive control normal human serum (NHS), as shown in ▶ Fig. 1 . The extract E1 (at concentration 183 µg/mL) inhibited 36.1 and 49.1 % of hemolysis by classical and alternative pathway, respectively. On the other hand, the extract E2 (at concentration 150 µg/mL) inhibited 34.2 and 49.9 % of hemolysis by classical and alternative pathways, respectively. The inhibitory effect of A. lappa extracts on the classical and alternative pathways was also observed at lower concentration, such as 22.88 µg/mL and 18.75 µg/mL for E1 and E2, respectively. The effect of both extracts and heparin on the complement activation was compared with the positive control of 50 % of hemolysis.
In addition, the half maximal inhibitory concentration (IC50) was 28. 26 
Discussion
Supercritical extracts from A. lappa leaves were able to inhibit complement activation by both classical and alternative pathways using functional assays (▶ Fig. 2 ). In addition, this inhibitory effect was observed at different concentrations of A. lappa extracts E1 and E2. Thus, ours results showed a dose-dependent inhibitory effect for both extracts on the activation of classical and alternative pathways.
Although several biological properties of A. lappa have been described [1] , our study is the first to describe its action as complement inhibitor. This immunomodulatory activity of A. lappa extracts corroborates with the anti-inflammatory actions previously reported such as activation of antioxidant enzymes and scavenging of free radicals [19, 21] , inhibition of inhibition of inducible nitric oxide synthase (iNOS) pathway [22] , suppression of pro-inflammatory cytokine expression [22] , inhibition of the nuclear factor-kappa B [23] , and inhibition of NOD-like receptor pyrin domain-containing-3 (NLRP3) inflammasome activation [5] .
It is noteworthy that the inhibitory effect of A. lappa extracts was 13 % (extract E1) to 15.7 % (extract E2) higher on the alternative when compared to classical pathway. This difference may be due to the inhibitory effect of the extracts on the initiating molecules, the ions involved (Ca and Mg), or preventing the formation of C3 and C5 convertases, which are specific for each pathway. Thus, the same extract may be more or less potent on different pathways. Furthermore, although the 3 complement pathways are triggered by different signals, the alternative pathway acts as an amplification loop of all pathways, corresponding to 80-90 % of C5 activation and MAC formation when classical pathway is activated [24, 25] . In addition, IC 50 for the extracts E1 (28.26 µg/mL; 26.12 µg/mL) and E2 (20.12 µg/mL; 27.70 µg/mL) were lower or similar to than those found to heparin (92.54 µg/mL; 27.78 µg/mL) on the activation of the classical and alternative pathway, respectively. These same extracts presented antioxidant activity with an IC 50 of 424 µg/mL and 383 µg/mL, for E1 and E2 [19] . These concentrations are at least 16 times higher than the concentrations found in our study, indicating a potent action of A. lappa extracts on complement.
Considering the similar results for the extracts E1 and E2 of A. lappa on complement activation assays, the different pressures and times of extraction of both samples do not appear to have affected the inhibitory properties of the extracted compounds. The predominant compounds with biological activity shared by extract E1 and E2 were the triterpenoids lupeol acetate and amyrin acetate and the diterpene phytol. These components have been described as anti-inflammatory substances [26, 27] . Lupeol acetate identified in Cariniana domestica (Mart.) Miers family Lecythidaceae and Bride-lia retusa (Spreng) family Euphorbiaceae presented anti-inflammatory effect in skin inflammation and in adjuvant-induced arthritis models [28, 29] . One of the anti-inflammatory mechanisms of lupeol acetate in arthritis models was the suppression of pro-inflammatory cytokines expression and inhibition of osteoclastogenesis [30] . Furthermore, lupeol acetate and amyrin acetate, detected as main components in extracts of Cnidoscolus chayamansa (Mc Vaugh) family Euphorbiaceae leaves, presented hepatoprotective and antiinflammatory activities in chronic models of liver damage [26] . Amyrin acetate isolated from Alstonia boonei De Wild family Apocynaceae showed significant inhibition in paw and ear edema models. It also reduced total leucocyte migration and neutrophil infiltration in vivo tests [31] . Our results corroborate the findings of Jin et al. [32] , who found that amyrin acetate isolated from the leaves and twigs of Acer okamotoanum Nakai family Aceraceae exhibited a significant inhibitory effect on activation of the classical pathway. The diterpene phytol was identified as the most abundant compound of Cleome rutidosperma DC family Cleomaceae aerial essential oil and exhibited antimicrobial activity against pathogenic bacteria and fungus strain [33] . Finally, diterpene phytol was shown also to decrease autoimmune response in both acute and chronic phases of experimental arthritis [27] , as well as phytol attenuates the inflammatory response in paw edema model by inhibiting neutrophil migration, reducing inflammatory cytokines levels and oxidative stress [34] .
It is important to consider that extracts composition can be influenced by extraction process conditions. Some compounds are more sensitive than others and, depending on the time of exposition to high temperatures or pressures, can be degraded. This may justify the lack of arctigenin in our extracts, a compound identified in fractions of A. lappa with an important anti-inflammatory role [35] [36] [37] . However, the anti-inflammatory activity observed with E1 and E2 extracts of A. lappa may be due to other components, such as lupeol, amyrin, and phytol [31, 34, 38] , which were also found in extracts from A. lappa leaves obtained by pressurized liquid extraction using aqueous ethanol [20] .
The present study also demonstrated that supercritical extraction using CO 2 as solvent results in extracts with important biological activities, as observed on complement activation. Moreover, the number of studies on plant compounds obtained by supercritical extraction has increased significantly in the last years, mainly due to their high applicability in health, herbal medicines, cosmetics, and nutraceutical foods [39] . The solvent CO 2 present some advantages as safety, availability, low cost, nontoxicity in low concentrations, nonflammable, and noncarcinogenic. The pressure and temperatures used in supercritical extractions are relatively low and safe [40] . Nevertheless, the solubility of CO 2 is limited to the nonpolar organic materials, the addition of a small amount of organic solvent, such as ethanol, may increase the solubility of polar compounds [41] . In addition, supercritical extraction is a field of interest for the pharmaceutical industry to exploit new plant species with potential medicinal use [42] .
One limitation in our study was the initial concentration from both extracts, since supercritical extraction method resulted in approximately 0.8 grams (3.5 %) from the whole leaf weight (22.8 g) used in the beginning of the extraction process. Thus, although there is a high demand for the substitution of synthetic substances for natural resources, sustainability is based on the abundance and availability of raw materials. As future perspectives, the effects of A. lappa extracts on the activation of the lectin pathway should be also considered, as well as the identification of the components responsible for the inhibitory effect on complement.
Considering that activation of the complement plays a central role in the maintenance of inflammation, the search for substances that modulate its activation is of great concern since only Eculizumab and C1 esterase-inhibitor are options approved by the U.S. Food and Drug Administration for complement inhibition [43] . Thus, our results contribute for the better understanding of the pharmacological and medicinal properties of A. lappa extracts highlighting its application as a complementary treatment for inflammatory diseases associated with complement activation in future clinical studies.
Materials and Methods
This work was approved by the Human Research Ethics Committee of the Federal University of Paraná (n. 1.703.531, approved in August 30, 2016).
Supercritical extracts
The raw material used in this study comprised of the aerial parts of A. lappa. All samples used belong to a single lot harvested in July 2016 from a local property in Ivaiporã (State of Paraná, Southern, Brazil) [19] . The raw material (A. lappa leaves) presented a residual moisture of 5.97 ± 0.02 wt %, average particle diameter of (1.3 ± 0.4)10 − 3 m, and real particle density of 1480 kg m − 3 , as described in a previous study by Souza et al. [19] . The extracts of A. lappa leaves were obtained by supercritical extraction using a bench-scale supercritical extraction unit, where CO 2 was used as solvent and ethanol as cosolvent. Two extraction conditions were performed, the extract 1 (E1) was obtained under 15 MPa in 50 min, the extract 2 (E2) under 25 MPa in 75 min (▶ Fig. 3) . The temperature was fixed at 313.15 K for both extracts. The extracts were analyzed by gas chromatography-mass spectrometry (Agilent 7890A/5975C GC-MS system), and the phytochemical compounds profile were identified by Souza et al. [19] as shown in ▶ table 1. We used the same samples described and evaluated by Souza et al. [19] to perform the complement assays.
Complement assays
Classical and alternative complement pathways activity were assessed by complement fixation tests adapted from Alban et al. [44] . HEPES buffer solution (HEPES 10 mM, 150 mM NaCl, pH 7.4) (HB) supplemented with 0.11 mM CaCl 2 and 0.5 mM MgCl 2 (HBC), or 7 mM MgCl 2 and 10 mM EGTA ph 7.4 (HBA) were used to evaluate the activation of classical and alternative pathways. The extracts E1 and E2 were dissolved in the minimum amount of solvent (HB with an addition of 20 % DMSO) capable of promoting their complete solubilization. The final concentration obtained for the extracts E1 and 
Preparation of sheep and rabbit erythrocytes suspensions
In order to analyze the activation of classical and alternative pathways, sheep (classical) and rabbit (alternative) red blood cells samples were commercially purchased (Kalifarma). Both erythrocytes were centrifuged (1500 g, 5 min), the supernatant removed, and the red blood cells washed 3 times with saline (0.9 % NaCl 
Statistical analysis
All experiments were performed in triplicate and the results expressed as mean and standard deviation. Data were analyzed by Kruskal Wallis with Dunn's multiple comparison as post-test ( * * * p < 0.001, * * p < 0.01 and * p < 0.05) and the IC 50 was calculated using GraphPad Prism 5 software. 
